TABLE 2.
M | KEGG pathway | p value |
---|---|---|
*a | Oxidative phosphorylation | <2.22e–16 |
* | Valine, leucine, and isoleucine degradation | <2.22e–16 |
* | Citrate cycle (trichloroacetic acid cycle) | <2.22e–16 |
* | Glycolysis/gluconeogenesis | <2.22e–16 |
* | Pyruvate metabolism | <2.22e–16 |
Carbon fixation | <2.22e–16 | |
Pentose phosphate pathway | <2.22e–16 | |
* | Fatty acid metabolism | <2.22e–16 |
* | Butanoate metabolism | <2.22e–16 |
* | Fatty acid elongation in mitochondria | <2.22e–16 |
* | Propanoate metabolism | <2.22e–16 |
Glycerophospholipid metabolism | <2.22e–16 | |
* | ATP synthesis | <2.22e–16 |
* | Lysine degradation | <2.22e–16 |
* | Benzoate degradation via CoA ligation | <2.22e–16 |
Insulin signaling pathway | <2.22e–16 | |
* | Reductive carboxylate cycle (CO2 fixation) | 4.29E–16 |
* | Glyoxylate and dicarboxylate metabolism | 4.80E–16 |
Biosynthesis of steroids | 9.69E–15 | |
Starch and sucrose metabolism | 2.01E–14 |
indicates a mitochondrial metabolic pathway (M)